(S)-1-Boc-3-Hydroxypiperidine CAS 143900-44-1 Ibrutinib Intermediate Purity >99.0% (GC)

Tlhaloso e Khutšoanyane:

Lebitso la Lik'hemik'hale: (S)-1-Boc-3-Hydroxypiperidine

CAS: 143900-44-1

Chiral Purity: >99.0% (GC)

Bohloeki ba Lik'hemik'hale: >99.0% (GC)

Ponahalo: Phofo e tšoeu kapa likristale

Bohareng ba Ibrutinib (CAS: 936563-96-1)

Boleng bo Phahameng, Tlhahiso ea Khoebo

E-Mail: alvin@ruifuchem.com


Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale (S) -1-Boc-3-Hydroxypiperidine
Litlhaloso tse tšoanang (S) -1-(tert-Butoxycarbonyl) -3-Hydroxypiperidine;(S)-1-Boc-3-Piperidinol
Nomoro ea CAS 143900-44-1
Nomoro ea KAtse RF-CC299
Boemo ba Setoko Ka Setokong, Bokhoni ba Tlhahiso 20 Tons/Khoeli
Foromo ea limolek'hule C10H19NO3
Boima ba Molek'hule 201.27
Melting Point 52.0 ~ 56.0℃
Solubility E qhibiliha ka Methanol
Phetoho e khethehileng [a]20/D +9.0°~+11.0° (C=1 ka Chloroform)
Brand Ruifu Chemical

Litlhaloso:

Ntho Litlhaloso
Ponahalo Phofo e tšoeu kapa Likristale
Chiral Purity >99.5% (GC)
Bohloeki ba Lik'hemik'hale >99.5% (GC)
Metsi (KF) ≤0.50%
Methanol (GC) ≤50ppm
Ethanol (GC) ≤50ppm
DCM (GC) ≤500ppm
3-Hydroxypiperidine ≤0.10%
3-Hydroxypyridine ≤0.20%
1-Boc-3-Piperidone ≤0.10%
1-Boc-4-Hydroxypiperidine ≤0.10%
1.96 RRT ≤0.20%
Tšilafalo efe kapa efe e sa Boleloeng ≤0.10%
Tekanyetso ea Teko Maemo a Khoebo
Tšebeliso Li-Intermediates tsa Meriana;Metsoako ea Chiral

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo.

Melemo:

1

LBH:

Kopo:

(S) -1-Boc-3-Hydroxypiperidine (CAS: 143900-44-1) ke setsi sa bohlokoa sa chiral bakeng sa motsoako oa Ibrutinib (CAS: 936563-96-1).Ibrutinib ke mofuta oa Bruton tyrosine kinase (BTK) inhibitor, e ka sebelisoa bakeng sa kalafo ea chronic lymphocytic leukemia (CLL) le mantle cell lymphoma (MCL).MCL le CLL ke tsa B-cell non-Hodgkin's lymphoma, eo ho leng thata ho e phekola le ho ipheta habonolo.Lik'hemik'hale tse tloaelehileng tsa immunotherapy ha li na sepheo, hangata li hlaha 3 kapa 4 karabelo e mpe.Li-lymphocyte tsa Ibrutinib le B li ne li ka shebana le BTK e hlokahalang bakeng sa ho thehoa, ho arola, le ho fetisa boitsebiso, ho thibela mosebetsi oa BTK ka mokhoa o sa fetoheng, le ho thibela ho ata ha lisele tsa hlahala le ho phela ka katleho.Ibrutinib e ka kenngoa ka potlako ka mor'a ho tsamaisoa ka molomo, nakong ea 1 ~ 2h e fihla ho bongata ba mali maling, karabelo e mpe ke ea motho a le mong kapa tse peli, ka hona, Ibrutinib e tla fetoha khetho e ncha ea kalafo ea CLL le MCL.

Ngola molaetsa wa hao mona mme o re romele wona